CANNAPHARMARX, INC. Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
CANNAPHARMARX, INC. (CPMD) reported Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature of $473.48 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-09-01.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature · last filed 2023-11-17
- CANNAPHARMARX, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2022-09-30 was $53.75K, a 33.70% decline year-over-year.
- CANNAPHARMARX, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2022-06-30 was $64.41K, a 77.74% decline year-over-year.
- CANNAPHARMARX, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2022-03-31 was $227.39K, a 564.77% increase year-over-year.
- CANNAPHARMARX, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2021-09-30 was $81.07K.
- CANNAPHARMARX, INC. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2022 was $473.48K, a 6.88% decline from fiscal 2021.
- CANNAPHARMARX, INC. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2021 was $508.45K.
- CANNAPHARMARX, INC. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2018 was $2.07M.
| Period end | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 3 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 6 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 9 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 12 month |
|---|---|---|---|---|
| 2022-12-31 | $473.48K 10-K · filed 2023-09-01 | |||
| 2022-09-30 | $53.75K 10-Q · filed 2023-11-17 | $118.16K derived: sum of 2 quarters · filed 2023-11-17 | $345.55K derived: sum of 3 quarters · filed 2023-11-17 | |
| 2022-06-30 | $64.41K 10-Q · filed 2023-11-17 | $291.80K derived: sum of 2 quarters · filed 2023-11-17 | ||
| 2022-03-31 | $227.39K 10-Q · filed 2023-11-17 | |||
| 2021-12-31 | $508.45K 10-K · filed 2023-09-01 | |||
| 2021-09-30 | $81.07K 10-Q · filed 2022-11-21 | $370.49K derived: sum of 2 quarters · filed 2022-11-21 | $404.70K derived: sum of 3 quarters · filed 2022-11-21 | |
| 2021-06-30 | $289.43K 10-Q · filed 2022-11-21 | $323.63K derived: sum of 2 quarters · filed 2022-11-21 | ||
| 2021-03-31 | $34.20K 10-Q · filed 2022-11-21 | |||
| 2018-12-31 | $2.07M 10-K · filed 2020-05-27 | |||
| 2018-09-30 | $905.00K 10-Q · filed 2019-11-14 |